/Companies

Porosome Therapeutics

Boston, US · Founded 2021 · Delaware corporation

Find your way into Porosome Therapeutics

Sign up to see every warm intro you have to Porosome Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Porosome Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

GM
Guillermo MarmolExecutive

Reported raises · per SEC filings

Form D private placements

$3.9M disclosed across 2 rounds · 2022–2023

▶$3.6MraisedMar 2026 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Guillermo MarmolExecutive Officer
Amount sold
$3.6M
Minimum investment
$50K
First sale
Sep 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$305KraisedJun 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Guillermo MarmolExecutive Officer
Amount sold
$305K
Minimum investment
$50K
First sale
Jun 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Porosome Therapeutics raised?
Porosome Therapeutics has disclosed $3.9M raised across 2 rounds.
Where is Porosome Therapeutics headquartered?
Porosome Therapeutics is headquartered in Boston, US.